DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,401 filers reported holding DANAHER CORPORATION in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,176,545 | +75.3% | 4,709 | +75.2% | 0.07% | +62.8% |
Q1 2024 | $671,248 | +4.3% | 2,688 | -3.4% | 0.04% | -4.4% |
Q4 2023 | $643,820 | -17.8% | 2,783 | -11.8% | 0.04% | -27.4% |
Q3 2023 | $783,252 | -0.3% | 3,157 | -3.5% | 0.06% | -1.6% |
Q2 2023 | $785,280 | -16.3% | 3,272 | -12.1% | 0.06% | -18.2% |
Q1 2023 | $938,093 | -20.1% | 3,722 | -15.9% | 0.08% | -26.0% |
Q4 2022 | $1,174,218 | +2.3% | 4,424 | -0.5% | 0.10% | -5.5% |
Q3 2022 | $1,148,000 | -4.1% | 4,447 | -5.8% | 0.11% | +2.8% |
Q2 2022 | $1,197,000 | -15.3% | 4,723 | -2.0% | 0.11% | -0.9% |
Q1 2022 | $1,414,000 | -3.8% | 4,819 | +7.9% | 0.11% | -2.7% |
Q4 2021 | $1,470,000 | +9.7% | 4,468 | +1.5% | 0.11% | -0.9% |
Q3 2021 | $1,340,000 | +12.4% | 4,403 | -0.8% | 0.11% | +5.7% |
Q2 2021 | $1,192,000 | +16.1% | 4,440 | -2.7% | 0.11% | +8.2% |
Q1 2021 | $1,027,000 | -9.0% | 4,564 | -10.1% | 0.10% | -16.2% |
Q4 2020 | $1,128,000 | -0.7% | 5,076 | -3.8% | 0.12% | -11.4% |
Q3 2020 | $1,136,000 | +20.0% | 5,276 | -1.4% | 0.13% | +3.9% |
Q2 2020 | $947,000 | -12.3% | 5,353 | -31.4% | 0.13% | -9.9% |
Q1 2020 | $1,080,000 | -16.1% | 7,802 | -7.0% | 0.14% | -9.6% |
Q4 2019 | $1,287,000 | +6.3% | 8,386 | 0.0% | 0.16% | 0.0% |
Q3 2019 | $1,211,000 | -0.1% | 8,386 | -1.1% | 0.16% | -4.9% |
Q2 2019 | $1,212,000 | +9.2% | 8,479 | +0.7% | 0.16% | +13.9% |
Q1 2019 | $1,110,000 | +34.9% | 8,423 | -0.0% | 0.14% | +8.3% |
Q4 2018 | $823,000 | -8.4% | 8,427 | +2.5% | 0.13% | -16.4% |
Q3 2018 | $898,000 | +7.4% | 8,220 | 0.0% | 0.16% | +1.9% |
Q2 2018 | $836,000 | +6.8% | 8,220 | +2.8% | 0.16% | +3.3% |
Q1 2018 | $783,000 | -7.1% | 8,000 | -11.9% | 0.15% | -6.2% |
Q4 2017 | $843,000 | +7.3% | 9,081 | 0.0% | 0.16% | -3.0% |
Q3 2017 | $786,000 | +2.6% | 9,081 | 0.0% | 0.17% | -4.6% |
Q2 2017 | $766,000 | +186.9% | 9,081 | +194.7% | 0.17% | +180.6% |
Q1 2017 | $267,000 | – | 3,081 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |